Neurology, Vol 45, Issue 11 2042-2050, Copyright © 1995 by American Academy of Neurology

ARTICLES

Prion disease (PrP-A117V) presenting with ataxia instead of dementia

JA Mastrianni, MT Curtis, JC Oberholtzer, MM Da Costa, S DeArmond, SB Prusiner and JY Garbern
Department of Neurology, University of California, San Francisco 94143- 0518, USA.

Gerstmann-Straussler-Scheinker disease (GSS) is caused by several different point mutations of the prion protein (PrP) gene, each of which generally produces a distinct clinical phenotype. An ataxic form of GSS is genetically linked to a mutation at codon 102 (CCG-->CTG) leading to the substitution of leucine for proline, while a "telencephalic" variant of GSS, in which dementia is the predominant symptom and ataxia is minimal, has been described in two kindreds with a mutation at codon 117 (GCA-->GTG) resulting in the substitution of valine for alanine. In this report, we present a family with ataxic GSS that has, however, the same mutation at codon 117 as is present in the telencephalic variant of GSS. Other than an additional silent mutation (GCA-->GCG) at codon 117 on the normal allele, there were no other mutations detected. At the polymorphic codon 129, valine was encoded by both alleles in the proband that we studied. Why this family with prion disease (PrP-A117V) should present with ataxia instead of dementia, which was found in two previously identified families with the same PrP gene mutation, remains to be established.

This article has been cited by other articles:

				S A Cooper, K L Murray, C A Heath, R G Will, and R S G Knight Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1273 - 1275. [Abstract] [Full Text] [PDF]

				G G Kovacs, C Ertsey, C Majtenyi, I Jelencsik, L Laszlo, H Flicker, L Strain, I Szirmai, and H Budka Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 802 - 805. [Abstract] [Full Text] [PDF]

				B. B. Worrall, L. P. Rowland, S. S.-M. Chin, and J. A. Mastrianni Amyotrophy in Prion Diseases Arch Neurol, January 1, 2000; 57(1): 33 - 38. [Abstract] [Full Text] [PDF]

				G. R. Mallucci, T. A. Campbell, A. Dickinson, J. Beck, M. Holt, G. Plant, K. W. de Pauw, R. N. Hakin, C. E. Clarke, S. Howell, et al. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene Brain, October 1, 1999; 122(10): 1823 - 1837. [Abstract] [Full Text] [PDF]

				R. S. Hegde, J. A. Mastrianni, M. R. Scott, K. A. DeFea, P. Tremblay, M. Torchia, S. J. DeArmond, S. B. Prusiner, and V. R. Lingappa A Transmembrane Form of the Prion Protein in Neurodegenerative Disease Science, February 6, 1998; 279(5352): 827 - 834. [Abstract] [Full Text]

				C Tranchant, N Sergeant, A Wattez, M Mohr, J M Warter, and A Delacourte Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation J. Neurol. Neurosurg. Psychiatry, August 1, 1997; 63(2): 240 - 246. [Abstract] [Full Text] [PDF]

				R. S. Stewart and D. A. Harris Most Pathogenic Mutations Do Not Alter the Membrane Topology of the Prion Protein J. Biol. Chem., January 12, 2001; 276(3): 2212 - 2220. [Abstract] [Full Text] [PDF]

				S. J. Kim, R. Rahbar, and R. S. Hegde Combinatorial Control of Prion Protein Biogenesis by the Signal Sequence and Transmembrane Domain J. Biol. Chem., July 6, 2001; 276(28): 26132 - 26140. [Abstract] [Full Text] [PDF]